View in EDS HTML Full Text PDF Full Text

Characterizing Adverse Events of Biologic Treatment of T2 Disease: A Disproportionality Analysis of the FDA Adverse Event Reporting System.

Saved in:
Bibliographic Details
Title: Characterizing Adverse Events of Biologic Treatment of T2 Disease: A Disproportionality Analysis of the FDA Adverse Event Reporting System.
Authors: Stack, Taylor J.1 (AUTHOR), Kim, Sulgi1 (AUTHOR), Lamb, Meredith M.1 (AUTHOR), Mohammad, Ibtisam1 (AUTHOR), Zeatoun, Abdullah1 (AUTHOR), Lopez, Erin1 (AUTHOR), Klatt-Cromwell, Cristine1 (AUTHOR), Thorp, Brian D.1 (AUTHOR), Ebert Jr., Charles S.1 (AUTHOR), Senior, Brent A.1 (AUTHOR), Kimple, Adam J.1 (AUTHOR), Alicea, Daniel1 (AUTHOR)
Source: ORL (0301-1569). 2023, Vol. 85 Issue 6, p329-339. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:03011569
DOI:10.1159/000534545